Editor(s):
(1) Dr. Takashi Ikeno, Clinical Research Support Office, Japan.
Reviewers:
(1) Doppalapudi Sandeep, Chebrolu Hanumaiah Institute Of Pharmaceutical Sciecnes, India.
(2) R Deveswaran, M.S.Ramaiah University of Applied Sciences, India.
(3) Muhammad Irfan Bashir, Universiti Sultan Zainal Abidin, Malaysia.
(4) Susmita Chakrabarty, DRIEMS University, India.
Additional Reviewers:
(1) Anilkumar J. Shinde, Bharati Vidyapeeth College of Pharmacy Kolhapur, India.
(2) Ghada Abd Alrhman Taqa, College of Dentistry, University of Mosul, Iraq.
(3) Khalida Ali Thejeel, Alkarkh University of science, Iraq.
(4) Lubna Alafandi, University of Aleppo, Syria.
(5) Precious Uahomo, Nigeria.
(6) Shyamalendu Tripathy, School of Pharmacy, Parul University, India.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 7.87/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (Doppalapudi Sandeep, India) | File 1 | NA
Stage 2 | Peer Review Report_2 (R Deveswaran, India) | File 1 | NA
Stage 2 | Peer Review Report_3 (Muhammad Irfan Bashir, Malaysia) | File 1 | NA
Stage 2 | Peer Review Report_4 (Susmita Chakrabarty, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA